CD69 and melanoma: Moreover, an increase of GZMB expression and upregulation of CD8+ T-cell activation markers, such as CD69, IFN-γ, CD25 and CD107, were detected in BRafV600E/Ptennull/Mi-2βnull melanomas after Mi-2β knockout.